New Blood Test Detects 90% of Aggressive Prostate Cancers
A new blood test, Stockholm3, detected 90% of aggressive prostate cancer cases in clinical trials, outperforming the traditional prostate-specific antigen (PSA) test, which identified 74%. According to a study published in the Annals of Internal Medicine, the test could improve early detection of curable disease while reducing unnecessary biopsies and MRIs for men aged 50 … Read more